The U.S. Department of Health and Human Services (HHS) has awarded a contract to Bavarian Nordic for the manufacture and delivery of 20 million doses of the company?s MVA based smallpox vaccine, IMVAMUNE?, for the protection of persons considered to be at risk for smallpox.
Very low doses of Novavax Inc.’s pandemic influenza vaccine provided protection against a lethal challenge of live H5N1 viruses, according to pre-clinical data presented here today at the Second International Conference on Avian Influenza in Humans.
Australian Health Minister Tony Abbott and Immigration Minister Kevin Andrews have advised Prime Minister John Howard to adopt a policy that would require HIV-positive migrants to report to health authorities within one month of arriving in Australia or risk losing their visas.
With 60 polio cases reported in India so far this year, the Indian Govt. has called a meeting of health ministers of 10 high-risk states next week to review the situation and chalk out future plans to eradicate the virus from the nation.
Rats with erectile dysfunction, or ED, that were injected with a gene therapy vector containing either of two nerve growth factors were able to regain normal function after four weeks, according to a study conducted by University of Pittsburgh School of Medicine researchers.
The Ministry of Health of Indonesia has announced a new case of human infection of H5N1 avian influenza.
Bird flu H5N1 strain of avian influenza was confirmed in a poultry worker in Vietnam, last week. The man has been hospitalized since last saturday and is recovering.
University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University School of Medicine are part of a nationwide research study to determine the safety and effectiveness of a new smallpox vaccine geared toward adults ages 18 to 34 who have never been vaccinated against the disease.
Researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
Researchers from the University of Pittsburgh School of Medicine report that they have successfully used gene therapy to block the pain response in an animal model of neuropathic pain, a type of chronic pain in people for which there are few effective treatments.